https://www.selleckchem.com/pr....oducts/-epicatechin.
No patients were lost to follow-up. Results Four-hundred-fifty-seven patients (493 primary aBM-lesions, 482 procedures) were included. Annual incidence of aBM-surgery was 46 aBM-lesions/million. MTC-patients had a significant better preoperative status than SSC-patients considering factors known for survival. Patients with complete fracture experienced longer surgical delay when treated at MTC compared to SSC 4 (1-9) and 1 (1-3) days (p 0.001), respectively. Overall survival for the entire cohort was 37% and 11% at 1 and 5 yea
Like
Comment
Share
